Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
stock market index
|
| gptkbp:basedOn |
January 1, 2021
|
| gptkbp:composedOf |
biotech stocks
|
| gptkbp:evaluates |
free float market capitalization
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nifty 50 Biotech Index
|
| gptkbp:includes |
companies_like_Biocon
companies_like_Dr._Reddy's_Laboratories companies_like_Serum_Institute_of_India companies_like_Sun_Pharmaceutical_Industries companies_like_Zydus_Cadila |
| gptkbp:isAssociatedWith |
biotech innovations
research and development in biotech |
| gptkbp:isAttendedBy |
economic conditions
market volatility market analysts |
| gptkbp:isChallengedBy |
biotech mutual funds
|
| gptkbp:isConsidered |
institutional investors
investment opportunity indicator of biotech sector health indicator of market sentiment |
| gptkbp:isDiscussedIn |
Indian Rupee
|
| gptkbp:isEvaluatedBy |
rating agencies
Nifty 50 performance |
| gptkbp:isInfluencedBy |
government policies
biotech sector performance technological advancements in biotech |
| gptkbp:isLinkedTo |
biotechnology advancements
healthcare_sector_performance |
| gptkbp:isMonitoredBy |
stock exchanges
|
| gptkbp:isPartOf |
Nifty 50
NSE indices family Nifty Pharma Index Nifty sectoral indices |
| gptkbp:isPortrayedBy |
financial analysts
financial news |
| gptkbp:isPublishedIn |
gptkb:National_Stock_Exchange_of_India
|
| gptkbp:isRecognizedFor |
leading_biotech_index_in_India
|
| gptkbp:isReferencedIn |
investment strategies
|
| gptkbp:isSubjectTo |
regulatory scrutiny
|
| gptkbp:isTrainedIn |
investors
|
| gptkbp:isUpdatedBy |
quarterly
|
| gptkbp:isUsedBy |
fund managers
|
| gptkbp:isUsedFor |
risk assessment
benchmarking investment performance |
| gptkbp:isUtilizedFor |
hedge funds
portfolio diversification global biotech trends |
| gptkbp:launched |
February 2021
|
| gptkbp:managedBy |
gptkb:NSE_Indices_Limited
|
| gptkbp:numberOfStudents |
1000
|
| gptkbp:track |
biotech companies
|